People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aadi Bioscience, Inc. | — | Biotechnology | Series D+ | $451.8M | $878.4M | 2025 |
| Bolt Biotherapeutics, Inc. | — | Biotechnology | Series C | $178.6M | $432.9M | 2020 |
David Dornan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Dornan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Miller | 1 | 8 |
| James Healy | 1 | 8 |
| Peter Moldt | 1 | 6 |
| Mahendra Shah | 1 | 5 |
| Edgar G Engleman | 1 | 5 |
| Paul M. Weiss | 1 | 4 |
| Emma Reeve | 1 | 4 |
| Mahendra G. Shah | 1 | 3 |
| Ashish Khanna | 1 | 3 |
| Neil Desai | 1 | 3 |
| Ashish G. Khanna | 1 | 2 |
| Chau M. Khuong | 1 | 2 |
| Anupam Dalal | 1 | 2 |
| Reiner Laus | 1 | 2 |
| Caley Castelein | 1 | 2 |
| Behzad Aghazadeh | 1 | 2 |
| Scott Giacobello | 1 | 2 |
| Chih-Ping Liu | 1 | 2 |
| Steven M. Prelack | 1 | 2 |
| Mohammad Hirmand | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.